Effectiveness of Prenatal Screening for Congenital Heart Disease in the Province of Alberta

  • Author / Creator
    Trines, Sharon Jean
  • Ultrasound technology has been available for several decades with it’s origins in science, industry and military innovations. Ultrasound imaging is a non invasive procedure used for many diagnostic purposes, and is a standard of care for pregnant women. Fetal growth can be followed and congenital anomalies, including congenital heart disease (CHD), can be identified. Screening for CHD is performed as part of routine prenatal care, usually between 18 to 24 weeks gestation. The effectiveness of screening for CHD in Alberta or Canada is not known but is low in other jurisdictions. This thesis: describes the impact of CHD on the patient, family and health care system; defines the capabilities of fetal echocardiography; determines the proportion of fetuses with CHD detected prenatally in Alberta; reports risk factors for missed disease; and describes clinical outcomes for those with and without a prenatal diagnosis.

  • Subjects / Keywords
  • Graduation date
  • Type of Item
  • Degree
    Master of Science
  • DOI
  • License
    This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for non-commercial purposes. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
  • Language
  • Institution
    University of Alberta
  • Degree level
  • Department
    • Department of Public Health Sciences
  • Specialization
    • Epidemiology
  • Supervisor / co-supervisor and their department(s)
    • Mackie, Andrew ( Department of Pediatrics)
    • Yasui, Yutaka (Public Health Sciences)
  • Examining committee members and their departments
    • Mitchell , Leslie ( Department of Pediatrics)
    • Mackie, Andrew ( Department of Pediatrics)
    • Yasui, Yutaka ( Public Health Sciences)